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Abstract Trimers of bovine pancreatic RNase A were obtained 
by cross-linking native RNase A with dimethyl suberimidate. 
They degrade double-stranded RNA more efficiently than dimers 
and monomers of RNase A, and display significant cytotoxic 
and/or cytostatic actions against C4-I cells (a human cell line 
derived from squamous carcinoma of the uterus cervix). On the 
same cell line cross-linked dimers of RNase A appear to be 
ineffective. 
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1. Introduction 
A distinctive feature of the RNA double-helix is its resist-
ance to digestion by bovine RNase A in 0.15-0.20 M NaCl 
solutions [1,2]. Under the same conditions dimers and higher 
aggregates of RNase A obtained by lyophilization from 30-
50% acetic acid solutions according to the procedure of Crest-
field et al. [3] are instead able to degrade double-stranded 
RNA (dsRNA) with an efficiency that increases as a function 
of the molecular mass of the aggregate(s) [4]. A remarkable 
degrading activity towards dsRNA was also shown by RNase 
A dimers obtained by cross-linkage with dimethyl suberimi-
date [5]. These dimers, at difference with those obtained by 
simple aggregation [3,4] are stabilized by a cross-link formed 
by the bifunctional reagent between lysine residues of two 
RNase monomers [5]. The novel catalytic activity acquired 
by RNase A in form of dimers, as well as the degrading ability 
shown towards dsRNA by other ribonucleases more basic 
than native RNase [6-8]A have been interpreted as due to a 
preferential binding of the various RNase species to short, 
transiently exposed single-stranded RNA sequences which 
are then degraded [4,6,7]. The extent of the 'destabilizing' 
event (and therefore of the degradation) seems to be corre-
lated with the number (or density, as it occurs with aggregated 
or cross-linked RNase A oligomers), and location of positive 
charges present on the enzyme protein [4,6-9]. 
Cross-linked dimers of bovine RNase A have also been 
shown to display an antitumor action both in vitro and in 
vivo [10,11]. A similar, but definitely higher antitumor activity 
[12,13], as well as other biological actions [14,15] are shown by 
bovine seminal RNase (BS RNase), which is the only native 
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dimeric ribonuclease known thus far [16]. This enzyme is also 
able to degrade efficiently dsRNA [17] and DNA-RNA hy-
brids [18]. Recently it was obtained a stable dimeric mutant 
RNase A, homogeneous and catalytically active, which dis-
played a selective toxicity for tumor cells similar to, but lower 
than, that of BS RNase [19]. 
Aim of the present work was to see whether cross-linked 
oligomers of bovine RNase A higher than dimers could show, 
in comparison with native RNase A and its dimers, a higher 
activity towards dsRNA and possibly an increased antitumor 
action. Both these features have been verified for trimeric 
RNase A. 
2. Materials and methods 
2.1. Preparation of RNase A cross-linked oligomers 
Bovine RNase A (type XII-A), purchased from Sigma, was cross-
linked with dimethyl suberimidate under conditions identical with 
those described by Wang et al. [5], who have carefully characterized 
the dimers produced in the reaction, also mentioning the presence of 
higher unresolved oligomers. The reaction was carried out for 15 min 
at pH 8.0 and 21°C with 1.25 mol equiv. of the diimido ester and a 
protein concentration of 6%. The unreacted reagent was quenched by 
the addition of 20 equiv. of ammonium acetate (as 0.2 M solution) per 
initial imido ester group. The mixture was then applied to a Pharma-
cia Superdex 75 HR 10/30 column (in a Pharmacia FPLC System) 
equilibrated with a 0.15 M NaCl/0.05 M sodium phosphate buffer, pH 
7. Elution was performed with the same buffer (flow rate, 0.1 ml/min 
at 25°C). Monomeric, dimeric, trimeric RNase A, as well as a small 
amount of tetrameric RNase A comprised in an unresolved mixture of 
higher oligomers, were identified (Fig. 1) using proteins of known 
molecular mass as calibration standards. These were Sigma products: 
bovine serum albumine (66 kDa), carbonic anhydrase (29 kDa), horse 
heart cytochrome C (12.4 kDa) and bovine lung aprotinin (6.5 kDa). 
To the mixture Dextran Blue (2000 kDa) was also added. The various 
RNase A species were also analyzed and identified by SDS-PAGE. 
Aggregated dimers (for which a molecular model has been proposed 
by Fruchter and Crestfield [20,21]) and trimers of bovine ribonuclease 
A were also prepared according to the procedure already described 
[3,4]. The concentration of RNase A was estimated spectrophotomet-
rically on the basis of e ^ of 7.3 [3]. 
2.2. Substrates 
Yeast RNA, purchased from Sigma, was purified according to 
Blackburn et al. [22]. The double-helical poly(A).poly(U) (sodium 
salt) was also a Sigma product. 
2.3. Enzymic assays 
The activity towards yeast RNA was determined by the spectro-
photometric assay of Kunitz [23], with 0.5 mg/ml of RNA in 0.1 M 
sodium acetate/acetic acid buffer, pH 5.0, at 25°C. Enzyme concen-
tration was 0.5 ug/ml for all RNA species. Specific activity values 
were calculated as Kunitz units/mg protein. Enzymic degradation of 
poly(A).poly(U) was determined spectrophotometrically [16] in 0.15 
M sodium chloride/0.015 M sodium citrate, pH 7, at 25°C. Substrate 
concentration was 0.11 mM in phosphodiester groups. The concen-
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tration of the various enzyme species ranged from 3 ng/ml (trimer) to 
12 ug/ml (monomer). Spectrophotometric measurements were per-
formed with a Beckman DU 650 spectrophotometer. The changes in 
absorbance following poly(A).poly(U) cleavage were continuously 
monitored. The increases in absorbance per min at 260 nm were 
deduced from the slope of the linear part of the recordings. Enzyme 
units were calculated (measuring initial velocities under conditions 
where [S]«Km) as change in absorbance per min/total measurable 
change [3,6]. Specific activity was defined as units/mg protein. The 
RNase monomer used in assays was always the enzyme species recov-
ered from the gel filtration experiment. 
2.4. Cell cultures 
C4-I cells - a human cell line derived from squamous carcinoma of 
the uterus cervix [24] - were purchased from ATCC, Rockwille, MD, 
USA. They were maintained in DME (Sigma) culture medium sup-
plemented with 5% (vol/vol) heat-inactivated (30 min at 56°C) fetal 
bovine serum (FBS, Hyclone, Celbio, Milan, Italy), and the antibiot-
ics Penicillin-G (200 U/ml) and Streptomicin (200 ug/ml) (Gibco BRL, 
Milan, Italy). Cells were kept in a 5% C02/95% air incubator at 37°C, 
and 48 h before treatment were seeded in 24 well-plates (Costar Italia, 
Milan, Italy) at a density of 6x 104 cells/well in 1 ml of culture me-
dium. 100 ug/ml of the various RNase A oligomers (in DME) were 
added to the cells and their effects (cytotoxicity and/or cytostaticity) 
monitored every 24 h, up to 72 h. 
2.5. Cell viability 
Viability of both treated and control-untreated cells was assessed by 
both Trypan Blue exclusion and the MTT (3, (4,5-dimethylthiazol-2-
yl) 2,5-diphenyl-tetrazolium bromide), slightly modified, assay [25]: 
every 24 h following treatment, 250 ul of the MTT solution (from a 
stock solution of 5 mg/ml in PBS) were added to the wells containing 
1 ml of culturing DME medium. The cells were incubated at 37°C for 
2 h to allow reaction to take place. Following the addition of 1 ml of 
lysing buffer (20% SDS in H2O/50:50 dimethyl formamide, 2.5% of 
80% acetic acid and 2.5% of 1 N HC1, pH 4.7), the MTT dyed 
cultures were incubated at room temperature for 15 min. Cell viability 
was estimated by measuring optical density in an ELISA scanner at 
570 nm wavelength (vs. 630 nm). 
3. Results 
3.1. Cross-linked oligomers of RNase A 
A gel filtration pattern of the cross-linked RNase A oligo-
mers is shown in Fig. 1. The separation obtained is an exam-
ple of one out of many similar, highly reproducible, experi-
ments performed with the product of six different 
preparations of cross-linked RNase A oligomers. Molecular 
mass values and relative amounts of the different RNase A 
species appear in Table 1. Besides monomeric, dimeric and 
trimeric RNase A, some higher and poorly resolved oligomers 
were also present, among which an RNase A tetramer could 
be identified, but in very small amount and heavily contami-
nated by other species. Only the fractions around the peak of 
Table 1 
Identification of RNase A oligomers 
Protein molecular mass (Da) 
RNase A Calculated8 Foundb Rel. amounts (%)c 
Monomer 
Dimer 
Trimer 
Higher oligomers 
13820 
27640 
41460 
1389511160 77.1012.18 
29150 + 2380 16.95+1.65 
4278013320 4.5810.41 
1.3910.13 
"Anhydrous molecular mass calculated from the amino acid compo-
sition, and increased by the presence of n residues of dimethyl sub-
erimidate (M.W. of each residue, 140 Da; n equal to the polymer-
ization degree). 
bEach value is the average ( 1 S.D.) of molecular mass determinations 
performed in 18 FPLC experiments (see Section 2). 
cEach value is the average ( 1 S.D.) of 7 measurements. 
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Fig. 1. Elution pattern of cross-linked oligomers of bovine RNase 
A. An aliquot (5.2 mg proteins) of a preparation of RNase A 
oligomers was applied to a Superdex 75 HR 10/30 column (Pharma-
cia FPLC System) equilibrated with 0.15 M NaCl/0.05 M sodium 
phosphate buffer, pH 7. Elution was performed with the same buff-
er at a flow rate of 0.1 ml/min at 25°C. T, D, M indicate trimer, 
dimer and monomer of RNase A. Higher, unresolved oligomers can 
also be noticed. 
each RNase oligomer were collected and used in the following 
experiments, after SDS-PAGE analysis. The results obtained 
by this procedure were coherent with those of the gel filtration 
experiments (see Fig. 1 and Table 1). Single bands were de-
tected whose positions corresponded to those expected for 
monomers, dimers and trimers of RNase A on the basis of 
the migration pattern of the proteins used as calibration 
standards (see Section 2). A band corresponding to a tetra-
meric form of RNase A was also present, although contami-
nated by other oligomeric species, as mentioned above. 
3.2. Enzyme activities of monomeric, dimeric and trimeric 
RNase A 
RNase A monomer, dimer and trimer were dialysed against 
2X 10~4 M NaCl, and concentrated. The action of these sta-
ble, cross-linked oligomers of RNase A towards poly(A). 
poly(U) was assayed in parallel with that of the corresponding 
oligomers obtained by simple aggregation [3,4] (Fig. 2a). Deg-
radation of dsRNA increased as a function of the molecular 
mass of the RNase A oligomers, but the cross-linked species 
were about 30% less active than the corresponding aggregated 
oligomers. While with the double-helical substrate cross-
linked or aggregated dimers and trimers of RNase A are def-
initely more active than the RNase A monomer, the contrary 
is true with yeast RNA as a substrate (Fig. 2b), in agreement 
with what previously reported with aggregated RNase A 
oligomers [4]. 
3.3. Action of RNase A oligomers on C4-I cells 
The action of trimeric RNase A on C4-I cells is shown in 
Fig. 3. Experiments were performed by adding 100 |ig/ml of 
the various RNase A species to the cell culture. The biological 
effects were determined every 24 h by Trypan Blue exclusion. 
As shown, treatment of C4-I cells with both the monomeric 
(M) and dimeric (D) forms of RNase A as well as with native 
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RNase A (A) did not induce significant changes in cell sur-
vival : up to 72 h the number of alive treated cells - similar to 
that of the control (C) - remained close to 100%. On the 
contrary, cross-linked trimers of RNase A (T) induced a rapid 
and massive increase in the number of Trypan Blue positive 
cells. 24 h after treatment was started, alive cells were about 
68%, this indicating a cytotoxic effect of the RNase A trimer 
on C4-I cells. However, 48 and 72 h following treatment only 
a small further decrease in the number of alive cells could be 
observed, which could be interpreted more as a cytostatic-like 
effect. Cell viability was also assessed by the MTT assay (data 
not shown), which did not show a decrease in cell metabolic 
activity. The same was true for C4-I cells treated with mono-
meric and dimeric RNase A or with native RNase A. It has 
also to be mentioned here that one out of six preparations of 
RNase A oligomers, although catalytically active on poly(A).-
poly(U) and yeast RNA, was found to be ineffective on C4-I 
cells. 
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Fig. 3. Antitumor activity of cross-linked RNase A oligomers. To 
cultures of C4-I cells 100 ug/ml of native RNase A ( A , A), mono-
meric RNase A recovered from the gel filtration column (O, M), di-
meric (•, D) and trimeric ( ♦ , T) RNase A were added; (o, 
C = Control) untreated cells. Cells were harvested every 24 h up to 
72 h, and their viability was assessed by Trypan Blue exclusion. The 
data represent means (±S.E.) of 11 experiments performed with the 
various RNase A species obtained in 5 different preparations of 
RNase A oligomers. 
4. Discussion 
M D T 
RNase A oligomers 
Fig. 2. Activity of cross-linked oligomers of RNase A on double-
and single-stranded RNAs. a: Monomers and cross-linked dimers 
and trimers of RNase A (dark bars) were assayed towards double-
stranded poly(A).poly(U) side-by-side with the corresponding aggre-
gated species (empty bars). Standard deviations are indicated. Sub-
strate concentration, 0.11 mM in phosphodiester groups. Enzyme 
concentration: trimer, 3 (ig/ml; dimer, 5.5 (ig/ml, monomer, 12 ug/ 
ml. Temp., 25°C. Spectrophotometric assay performed as described 
[17] (see also Section 2). The data with cross-linked oligomers are 
means of 7 independent experiments; those with the aggregated 
oligomers [3] are means of 5 independent experiments, b: Activity 
(Kunitz assay [23]) of monomeric RNase A and cross-linked (dark 
bars; means of 4 independent experiments) or aggregated (empty 
bars; means of 3 independent experiments) RNase A oligomers on 
yeast RNA. Standard deviations are indicated. Substrate concentra-
tion, 0.5 mg/ml. Enzyme concentration, 0.5 ug/ml. Temp., 25°C. 
Trimers of bovine RNase A, prepared by cross-linkage with 
dimethyl suberimidate, show a definite activity, higher than 
that of RNase A dimers and monomers, towards dsRNA. 
They also show a remarkable antitumor action in vitro. 
With the cell line (C4-I) used by us, dimeric RNase A appears 
instead to be ineffective (see Fig. 3), contrary to what reported 
by others, but with different cell lines [10,11]. 
4.1. Catalytic activity of RNase A trimers towards dsRNA 
It is known that the RNA double-helix in its canonic form 
protects dsRNA from base-catalyzed cleavage since the ster-
eochemical requirements for the transesterification reaction 
cannot be met [2,26]. DsRNA is indeed resistant to digestion 
by pancreatic ribonuclease A at physiological ionic strength. 
However, aggregated oligomers (from dimers up to hexamers) 
of bovine RNase A - the prototype of single-strand-preferring 
RNases (6,7) - cleave dsRNA with an efficiency that increases 
exponentially as a function of the molecular mass of the ag-
gregates [4]. RNase A in form of cross-linked dimers was also 
shown to acquire a significant activity towards dsRNA [5] and 
DNA-RNA hybrids [27]. On the other hand, several mamma-
lian single-strand-preferring ribonucleases of the pancreatic 
type, monomeric but endowed with a higher basicity than 
bovine RNase A, are also able to degrade dsRNA with a 
remarkably high efficiency [6-8]. These results have been ex-
plained on the basis of the following arguments. A correlation 
was demonstrated between the number (or density) and loca-
tion (in the region of the active site) of the positive charges 
G. Gotte et al.lFEBS Letters 415 (1997) 308-312 311 
present on various RNases and their ability to destabilize 
double-helical polydeoxyribonucleotides [6-9]. This destabiliz-
ing action (in the terms proposed by Jensen and von Hippel 
[28] for RNase A), that can be envisaged to also occur with 
dsRNA, would in this case represent the necessary event for 
the enzymic cleavage of the resulting single-stranded RNA 
sequences [4,6,7]. Here we show that a cross-linked trimer of 
bovine RNase A has an activity towards dsRNA higher than 
that of cross-linked dimers. This fact can easily be explained 
in the light of the hypothesis mentioned above. RNase A 
oligomers, and pancreatic-type RNases more basic than 
RNase A could indeed be regarded as nucleic acid-melting 
proteins which can bind short sequences of dsRNA transiently 
made single-stranded by the dynamic 'breathing' of the RNA 
double-helix [2,6,7]. A complementary model, consisting in the 
binding by the RNase of single, wound off ribonucleotides, 
has been proposed by Yakovlev et al. [29]. As for the lower 
activity, in comparison with that of monomers, of cross-linked 
dimers and trimers of RNase A on yeast RNA, it agrees with 
what was observed with aggregated RNase A oligomers [4] 
and could be ascribed to a lower catalytic efficiency (per active 
center) of the oligomeric form of the enzyme, whose active 
sites might not all be simultaneously available. 
4.2. Cytotoxic and cytostatic action of RNase A trimers on 
C4-I cells 
Bartholeyns and Baudhuin [10], and others [11] have shown 
that cross-linked dimers of RNase A have a significant cyto-
static action against tumor cells both in vitro and in vivo, 
similar but definitely lower than that displayed by BS RNase 
[12,13], which is the only known ribonuclease dimeric in na-
ture [16]. Recently, Di Donato et al. [19] have prepared an 
RNase A mutant that spontaneously dimerizes forming mol-
ecules structurally similar to BS RNase, and endowed with a 
similar although lower antitumor activity. 
In this work we have shown that cross-linked trimers of 
RNase A, added to a human cell line derived from squamous 
carcinoma of the uterus cervix, display a remarkable cytotoxic 
effect in the first 24 h following treatment. From 24 h up to 72 
h a cytostatic-like effect could instead be observed. No change 
in the metabolic activity of C4-I cells could be measured by 
the MTT assay. However, this could just mean an increase in 
the metabolic activity of the surviving cells. All together these 
results cannot be easily explained, particularly if one takes 
into account that, contrary to what was reported using differ-
ent cell lines [10,11], dimeric RNase A seems to be ineffective 
on C4-I cells. At the moment we lack any information about 
the fate of cross-linked RNase A trimers in the cell culture, 
and the manner in which they interact with the cells. More-
over, we also do not know whether their cytotoxic and cyto-
static actions could in some way be related to their activity 
towards dsRNA. Therefore, the hypotheses already advanced 
to explain the biological actions of BS RNase [30,31], the 
dimeric RNase A mutant [19] or the cross-linked dimers of 
bovine RNase A [10,11] cannot be easily applied to the results 
reported here. However, one point seems to be clear, i.e. that 
the cytotoxic and/or cytostatic actions of those ribonucleases 
cannot be ascribed (besides other possible determinants) to 
the dimeric nature of the enzymes. More than the dimeric 
structure of the proteins in itself, the insensitivity of the di-
meric biologically active form of BS RNase and of the dimeric 
mutant of RNase A to the RNase inhibitor is a feature that 
could correlate with the antitumor action of these enzymes 
[19,30-32]. The RNase inhibitor binds indeed tightly to the 
monomeric forms of these RNases. Thus, a particular dimeric 
structure of the enzyme could represent a sterical obstacle for 
the specific amino acid residues responsible for the binding of 
the ribonuclease to the RNase inhibitor. This idea could in-
deed be extended to the cross-linked trimers of bovine RNase 
A obtained by us. An example pertinent to this point could be 
the observation that onconase (a monomeric ribonuclease 
from Rana pipiens oocytes [33-35]) is resistant to the RNase 
A inhibitor, and displays a strong antitumor action [34,35]. 
Therefore, the intrinsic absence of proper residues necessary 
for the binding of the ribonuclease to the RNase inhibitor, as 
it occurs in onconase [35], or their sterical masking seem to be 
important prerequisites for ribonuclease cytotoxicity. With re-
gard to these points and to the biological actions of ribonu-
cleases in general [14,15], interesting can also be the observa-
tion [15] that angiogenin, a monomeric [36,37] member of the 
ribonuclease superfamily [38] shows an immunosuppressive 
activity that is quite similar to that displayed by the dimeric 
BS RNase. 
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